Sign in
4

Changes in Ownership

Moleculin Biotech, Inc. Filed Acc 0001437749-23-018141

Chief Financial Officer gave up 9,676 shares (to pay taxes)

  • Chief Financial Officer acquired 40,667 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Foster Jonathan P. Chief Financial Officer 2023-06-20 Option exercise +40,667 61,246 D
Foster Jonathan P. Chief Financial Officer 2023-06-20 Shares withheld for taxes −9,676 $0.57 $5,515 51,570 D
Derivatives
Foster Jonathan P. Chief Financial Officer 2023-06-20 Option exercise · Restricted Stock Units −40,667 680,938 D
Loading xslF345X04/rdgdoc.xml…